drugset / Trial / NCT01372930
Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
RandomizedParallel-groupOpen-labelTreatment
Summary
Our aim is to observe whether anti-TNF-alpha regimen will effect serum adiponectin concentration after myocardial infarction/reperfusion and also beneficial for the patients undergoing percutaneous coronary intervention (PCI).
Timeline
- Start
- 2010-04
- Primary completion
- 2014-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 25 mg | Subcutaneous |